- Home
- ATXS vs NGL Comparison
ATXS vs NGL Comparison
Compare ATXS & NGL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ATXS
- NGL
- Stock Information
- Founded
- ATXS 2008
- NGL 1940
- Country
- ATXS United States
- NGL United States
- Employees
- ATXS N/A
- NGL N/A
- Industry
- ATXS Biotechnology: Pharmaceutical Preparations
- NGL Natural Gas Distribution
- Sector
- ATXS Health Care
- NGL Utilities
- Exchange
- ATXS Nasdaq
- NGL Nasdaq
- Market Cap
- ATXS 676.1M
- NGL 751.7M
- IPO Year
- ATXS 2015
- NGL 2011
- Fundamental
- Price
- ATXS $12.46
- NGL $6.27
- Analyst Decision
- ATXS Buy
- NGL
- Analyst Count
- ATXS 7
- NGL 0
- Target Price
- ATXS $30.00
- NGL N/A
- AVG Volume (30 Days)
- ATXS 4.1M
- NGL 281.6K
- Earning Date
- ATXS 11-12-2025
- NGL 11-04-2025
- Dividend Yield
- ATXS N/A
- NGL N/A
- EPS Growth
- ATXS N/A
- NGL N/A
- EPS
- ATXS N/A
- NGL N/A
- Revenue
- ATXS N/A
- NGL $3,332,108,000.00
- Revenue This Year
- ATXS N/A
- NGL N/A
- Revenue Next Year
- ATXS N/A
- NGL N/A
- P/E Ratio
- ATXS N/A
- NGL N/A
- Revenue Growth
- ATXS N/A
- NGL 1.08
- 52 Week Low
- ATXS $3.56
- NGL $2.64
- 52 Week High
- ATXS $12.55
- NGL $7.15
- Technical
- Relative Strength Index (RSI)
- ATXS 84.72
- NGL 55.79
- Support Level
- ATXS $11.83
- NGL $6.04
- Resistance Level
- ATXS $12.16
- NGL $6.50
- Average True Range (ATR)
- ATXS 0.36
- NGL 0.19
- MACD
- ATXS 0.26
- NGL -0.02
- Stochastic Oscillator
- ATXS 97.97
- NGL 47.80
About ATXS Astria Therapeutics Inc.
Astria Therapeutics Inc is a biopharmaceutical company engaged to bring life-changing therapies to patients and families affected by rare and niche allergic and immunological diseases. Its program, STAR-0215, is a monoclonal antibody inhibitor of plasma kallikrein in preclinical development for the treatment of hereditary angioedema. Their second product candidate is STAR-0310, a monoclonal antibody OX40 antagonist that is in preclinical development for the treatment of atopic dermatitis, or AD, an immune disorder associated with loss of skin barrier function and itching.
About NGL NGL ENERGY PARTNERS LP Common Units representing Limited Partner Interests
NGL Energy Partners LP is a USA-based firm that owns and operates a vertically integrated energy business. The company's operating segments include Crude Oil Logistics, Water Solutions, and Liquids Logistics. It operates crude oil Logistics, owns pipeline injection stations, and offers services for the treatment and disposal of wastewater generated from crude oil and natural gas production, as well as for the disposal of solids, such as tank bottoms and drilling fluids. The firm also supplies natural gas liquids to retailers, wholesalers, refiners, and petrochemical plants and sells propane and distillates.